- Global Real-World Outcomes of Patients Receiving Immuno-Oncology Combinations for Advanced Renal Cell Carcinoma: The ARON-1 Study2023 | 1. lékařská fakulta, Lékařská fakulta v Plzni, Lékařská fakulta v Hradci Králové
- Clinico-Pathological Features Influencing the Prognostic Role of Body Mass Index in Patients With Advanced Renal Cell Carcinoma Treated by Immuno-Oncology Combinations (ARON-1)2023 | 1. lékařská fakulta, Lékařská fakulta v Plzni
- Geographical differences in the management of metastatic de novo renal cell carcinoma in the era of immune-combinations2023 | 1. lékařská fakulta, Lékařská fakulta v Plzni, Lékařská fakulta v Hradci Králové
- Concomitant Use of Statins, Metformin, or Proton Pump Inhibitors in Patients with Advanced Renal Cell Carcinoma Treated with First-Line Combination Therapies2022 | 1. lékařská fakulta